Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $114.5600 (-1.16%) ($114.1920 - $116.0000) on Tue. May. 25, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.24% (three month average) | RSI | 46 | Latest Price | $114.5600(-1.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.5% a day on average for past five trading days. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(45%) SPLV(36%) XLP(33%) VYM(32%) DIA(31%) | Factors Impacting ABBV price | ABBV will decline at least -0.62% in a week (0% probabilities). VIXM(-20%) UUP(-10%) VXX(-2%) TLT(-2%) KWEB(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.62% (StdDev 1.24%) | Hourly BBV | -1.4 () | Intraday Trend | -1.2% | | | |
|
Resistance Level | $115.24 | 5 Day Moving Average | $115.91(-1.16%) | 10 Day Moving Average | $116.15(-1.37%) | 20 Day Moving Average | $115.24(-0.59%) | To recent high | -2.3% | To recent low | 11.2% | Market Cap | $202.116b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |